The In vitro diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient awareness, continue to fuel growth in global IVD market. With increasing technological advancements in global diagnostic market, the worldwide IVD market reported a growth of around 8.5% in 2008 as compared to 2007.
According to our latest research report, “Global In Vitro Diagnostic Market Analysis”, the global IVD market is forecasted to grow at a CAGR of around 9% during 2010-2012. Currently, the IVD market is particularly characterized by the emergence of various novel technologies, with molecular diagnostics and point of care tests expected to play a very important role in driving the future growth of the market worldwide. In terms of disease testing, blood glucose monitoring and cancer testing segments are expected to dominate the market in near future.
We have done extensive research in order to identify current trends in the key markets across the world. We have found that point of care test segment has continued dominating the current IVD market, while higher growth rate was witnessed in the molecular diagnostic segment during 2008. The molecular diagnostic market is anticipated to grow at a CAGR of about 14% during 2010-2012. In this regard, our report provides rational analysis of various factors which will drive this market segment over the forecast period.
This report also provides extensive information on the traditional IVD testing markets as well as on the emerging technologies. Also, an insight of the trends prevailing in the regional IVD markets across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution and trends in technology development have been thoroughly studied in the report to give a comprehensive overview of the IVD market.
